GSA Capital Partners LLP Decreases Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

GSA Capital Partners LLP reduced its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 25.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 39,925 shares of the company’s stock after selling 13,679 shares during the period. GSA Capital Partners LLP owned approximately 0.08% of Prestige Consumer Healthcare worth $2,879,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in PBH. Boston Trust Walden Corp purchased a new stake in shares of Prestige Consumer Healthcare during the 3rd quarter worth $41,785,000. Ariel Investments LLC boosted its position in shares of Prestige Consumer Healthcare by 10.7% in the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock worth $195,204,000 after buying an additional 274,212 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Prestige Consumer Healthcare by 26.0% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock worth $90,891,000 after buying an additional 272,773 shares in the last quarter. Victory Capital Management Inc. boosted its position in shares of Prestige Consumer Healthcare by 9.0% in the 2nd quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock worth $142,827,000 after buying an additional 171,357 shares in the last quarter. Finally, F M Investments LLC purchased a new stake in shares of Prestige Consumer Healthcare in the 2nd quarter worth about $11,162,000. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Trading Up 1.7 %

Shares of PBH stock opened at $81.75 on Tuesday. The firm has a 50-day moving average price of $72.55 and a 200 day moving average price of $69.84. Prestige Consumer Healthcare Inc. has a twelve month low of $56.61 and a twelve month high of $82.00. The company has a market capitalization of $4.05 billion, a price-to-earnings ratio of 19.79, a PEG ratio of 2.27 and a beta of 0.47. The company has a current ratio of 3.56, a quick ratio of 1.90 and a debt-to-equity ratio of 0.61.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting the consensus estimate of $1.09. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The firm had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. During the same quarter in the previous year, the company posted $1.07 EPS. The firm’s revenue for the quarter was down .9% on a year-over-year basis. Research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.44 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

PBH has been the topic of several recent research reports. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. DA Davidson reiterated a “buy” rating and issued a $95.00 price objective on shares of Prestige Consumer Healthcare in a research report on Monday. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.